University of Texas Health San Antonio researchers became the first to publish results of the treatment of an age-related disease, idiopathic pulmonary fibrosis (IPF), in human patients with drugs called senolytics.  Previously, no published data demonstrated that drugs targeting cellular senescence could be safely given to adults or that they might be used to treat diseases of aging. (ScienceDaily)